FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter von dem Borne

Research Profile

Chemicals & Drugs

Physiology

Procedures

Anatomy

Disorders

Oral Ulcer

Co-author Network

Publications

TOP 3
Alexa M G A Laheij; Johannes J de Soet; Eefje A Kraneveld; Ed J Kuijper; Cor van Loveren; Peter A von dem Borne; Judith E Raber-Durlacher
Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients.
Pauline Meij; Marian van de Meent; P L J van der Heiden; H M Esther van Egmond; Ellis van Liempt; Sabrina Veld; Peter A von dem Borne; Maarten L Zandvliet; Constantijn J M Halkes; Conny Hoogstraten; Inge Jedema; Simone Kruithof; Arjan C Lankester; Erik W A Marijt; J H Frederik Falkenburg
Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines.
Boris van der Zouwen; Peter A von dem Borne; J H Frederik Falkenburg; Ekaterina S. Jordanova; Alwine B Kruisselbrink; Caroline E Rutten; Inge Jedema
Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter von dem Borne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alexa M G A Laheij; Johannes J de Soet; Eefje A Kraneveld; Ed J Kuijper; Cor van Loveren; Peter A von dem Borne; Judith E Raber-Durlacher
Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(12):3231-40.
2012: Pauline Meij; Marian van de Meent; P L J van der Heiden; H M Esther van Egmond; Ellis van Liempt; Sabrina Veld; Peter A von dem Borne; Maarten L Zandvliet; Constantijn J M Halkes; Conny Hoogstraten; Inge Jedema; Simone Kruithof; Arjan C Lankester; Erik W A Marijt; J H Frederik Falkenburg
Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012;35(8):621-8.
2012: Boris van der Zouwen; Peter A von dem Borne; J H Frederik Falkenburg; Ekaterina S. Jordanova; Alwine B Kruisselbrink; Caroline E Rutten; Inge Jedema
Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivity.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1353-67.
2012: M T van der Beek; C S van der Blij-de Brouwer; C van Loveren; Peter A von dem Borne; E C J Claas; J J de Soet; A C M Kroes; A M G A Laheij; J E Raber-Durlacher; Ron Wolterbeek; A C T M Vossen
Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients.
Bone marrow transplantation 2012;47(9):1222-8.
2012: Marjolein Knoester; Aloys C M Kroes; Peter A von dem Borne; A C T M Vossen; Eric C J Claas
Human parvovirus B19 genotype 3 associated with chronic anemia after stem cell transplantation, missed by routine PCR testing.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2012;54(4):368-70.
2012: M H ten Brink; Tahar van der Straaten; Peter A von dem Borne; J A Wessels; H-J Guchelaar; J den Hartigh; J Zwaveling
Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT.
Bone marrow transplantation 2012;47(2):190-5.
2011: Pleun Hombrink; Michel Kester; Schumacher Ton; Peter A von dem Borne; Arne Bakker; J H Frederik Falkenburg; Sine Reker Hadrup; Mirjam H M Heemskerk
High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.
PloS one 2011;6(8):e22523.
2009: Martijn P Bauer; Nathalie D van Burgel; W A Erik Marijt; Jaap T van Dissel; Peter A von dem Borne
Fever, shock, and pancytopenia in a patient treated with alemtuzumab.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(10):1540; 1616-7.
2008: Peter A von dem Borne; C W J Ingrid Starrenburg; Renée M Y Barge; Erik W A Marijt; J H Frederik Falkenburg; Rein Willemze
Comparable engraftment and chimerism kinetics using oral and intravenous fludarabine as part of a reduced intensity conditioning regimen.
Bone marrow transplantation 2008;42(2):137-8.
2008: Marloes S van Kester; Jacoba J Out-Luiting; Peter A von dem Borne; Rein Willemze; Cornelis P Tensen; Maarten H Vermeer
Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells.
The Journal of investigative dermatology 2008;128(7):1691-5.
2008: Marieke Griffioen; Edith D van der Meijden; Elisabeth H Slager; M Willy Honders; Caroline E Rutten; S A P van Luxemburg-Heijs; Peter A von dem Borne; Jon van Rood; Roel Willemze; J H Frederik Falkenburg
Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(10):3837-42.
2007: Jeltje F de Vries; Peter A von dem Borne; S A P van Luxemburg-Heijs; Mirjam H M Heemskerk; Rein Willemze; J H Frederik Falkenburg; Renée M Y Barge
Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing.
Haematologica 2007;92(12):1671-8.
2006: Peter A von dem Borne; Floor Beaumont; C W J Ingrid Starrenburg; Machteld Oudshoorn; Geoff Hale; J H Frederik Falkenburg; Willem E Fibbe; Rein Willemze; Renée M Y Barge
Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab.
Haematologica 2006;91(11):1559-62.
2006: Peter A von dem Borne; Linda M P Cox; Bonno N Bouma
Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2006;17(4):251-7.
2006: Peter A von dem Borne; S A P van Luxemburg-Heijs; Mirjam H M Heemskerk; Inge Jedema; Arend Mulder; Rein Willemze; J H Frederik Falkenburg
Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells.
Leukemia 2006;20(6):1040-6.
2006: Rogier M Bertina; Nico H van Tilburg; Frits Haverkate; Bonno N Bouma; Peter A von dem Borne; Joost C M Meijers; W Campbell; D Eaton; Dirk F Hendriks; Johan L Willemse
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI).
Journal of thrombosis and haemostasis : JTH 2006;4(1):256-7.
2001: Albert van de Wiel; Pierre M van Golde; Rob J Kraaijenhagen; Peter A von dem Borne; Bonno N Bouma; H C Hart
Acute inhibitory effect of alcohol on fibrinolysis.
European journal of clinical investigation 2001;31(2):164-70.
1998: Laurent O Mosnier; Peter A von dem Borne; Joost C M Meijers; Bonno N Bouma
Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
Thrombosis and haemostasis 1998;80(5):829-35.
1998: Bonno N Bouma; Peter A von dem Borne; Joost C M Meijers
Factor XI and protection of the fibrin clot against lysis--a role for the intrinsic pathway of coagulation in fibrinolysis.
Thrombosis and haemostasis 1998;80(1):24-7.
1998: MG Elisen; Peter A von dem Borne; Bonno N Bouma; Joost C M Meijers
Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Blood 1998;91(5):1542-7.
1998: Marjolijn Bornebroek; Peter A von dem Borne; Joost Haan; Joost C M Meijers; William E Van Nostrand; R A Ross
Binding of amyloid beta precursor protein to coagulation factor XIa in vivo may favour haemorrhagic stroke.
Journal of neurology 1998;245(2):111-5.
1998: MC Minnema; Philip W Friederich; Marcel Levi; Peter A von dem Borne; Laurent O Mosnier; Joost C M Meijers; Bart J Biemond; C Erik Hack; Bonno N Bouma; Hugo ten Cate
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.
The Journal of clinical investigation 1998;101(1):10-4.
1997: Peter A von dem Borne; Laurent O Mosnier; G Tans; Joost C M Meijers; Bonno N Bouma
Factor XI activation by meizothrombin: stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine.
Thrombosis and haemostasis 1997;78(2):834-9.
1997: Peter A von dem Borne; Laszlo Bajzar; Joost C M Meijers; Michael E Nesheim; Bonno N Bouma
Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
The Journal of clinical investigation 1997;99(10):2323-7.
1996: Peter A von dem Borne; Joost C M Meijers; Bonno N Bouma
Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
Thrombosis and haemostasis 1996;76(3):347-53.
1995: Peter A von dem Borne; Joost C M Meijers; Bonno N Bouma
Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.
Blood 1995;86(8):3035-42.
1994: Peter A von dem Borne; S J Koppelman; Bonno N Bouma; Joost C M Meijers
Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen.
Thrombosis and haemostasis 1994;72(3):397-402.